CVS Health Gross Unrealized Gains increased by 33.1% to $462.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.4%, from $510.00M to $462.00M. Over 4 years (FY 2020 to FY 2024), Gross Unrealized Gains shows a downward trend with a -43.9% CAGR.
other_available_for_sale_debt_securities_accumulated_gro_8d5dbc| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.44B | $1.31B | $1.17B | $428.00M | $65.00M | $26.00M | $57.00M | $101.00M | $69.00M | $35.00M | $267.00M | $191.00M | $146.00M | $510.00M | $178.00M | $246.00M | $347.00M | $462.00M |
| QoQ Change | — | -8.9% | -10.7% | -63.5% | -84.8% | -60.0% | +119.2% | +77.2% | -31.7% | -49.3% | +662.9% | -28.5% | -23.6% | +249.3% | -65.1% | +38.2% | +41.1% | +33.1% |
| YoY Change | — | — | — | — | -95.5% | -98.0% | -95.1% | -76.4% | +6.2% | +34.6% | +368.4% | +89.1% | +111.6% | >999% | -33.3% | +28.8% | +137.7% | -9.4% |